glp-1 drugs medicare is now covering some weight loss for $50. Here's what to know Medicare to Offer GLP-1 Drugs

Semaglutide: GLP-1 receptor agonist developed for type 2 diabetes Controls blood sugar, reduces appetite, and slows digestion FDA-approved for chronic weight management (Wegovy) Injected once weekly Learn more on our Semaglutide weight loss page Phentermine: Appetite suppressant in the amphetamine family Stimulates the central nervous system to reduce hunger FDA-approved since 1959 for short-term weight loss Taken orally, typically once daily Read about our Tirzepatide Medical Weight Loss Program How Do They Work Differently

Information for Medicare beneficiaries

This can be achieved through dietary stimulants, pharmacological agents, or interventions targeting the gut microbiota

It means they mimic the gut hormone GLP-1 to help regulate appetite, improve blood sugar, and slow digestion

doi:10.1001/jamanetworkopen.2025.26321,

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis